[Drug therapy of malignant tumors of the skin. Bleomycin].
作者信息
Ocaña Sierra J
出版信息
Actas Dermosifiliogr. 1975 Mar-Apr;66(3-4):159-78.
PMID:51577
Abstract
摘要
相似文献
1
[Drug therapy of malignant tumors of the skin. Bleomycin].[皮肤恶性肿瘤的药物治疗。博来霉素]
Actas Dermosifiliogr. 1975 Mar-Apr;66(3-4):159-78.
2
[Clinical experience with NK 631 in malignant tumors of skin (author's transl)].NK 631治疗皮肤恶性肿瘤的临床经验（作者译）
Jpn J Antibiot. 1979 Mar;32(3):463-9.
3
Clinical efficiency of bleomycin in oesophageal and skin carcinoma in East Africa.博来霉素在东非食管癌和皮肤癌治疗中的临床疗效。
East Afr Med J. 1973 Aug;50(8):449-53.
4
[Extensive disseminated cutaneous neoplasms; role of cytophotometry in determining the correct chemotherapy].[广泛播散性皮肤肿瘤；细胞光度测定法在确定正确化疗方案中的作用]
Ann Dermatol Venereol. 1978 Apr;105(4):443-5.
5
[Bleomycin and skin neoplasms].[博来霉素与皮肤肿瘤]
Arch Belg Dermatol Syphiligr. 1971 Jul-Sep;27(3):233-9.
6
Lomustine, bleomycin, and cisplatin in patients with metastatic malignant melanoma.洛莫司汀、博来霉素和顺铂用于转移性恶性黑色素瘤患者。
Cancer Treat Rep. 1986 May;70(5):688-9.
7
Clinical study with bleomycin: tolerance to twice weekly dosage.博来霉素的临床研究：对每周两次给药剂量的耐受性
Cancer. 1972 Oct;30(4):914-22. doi: 10.1002/1097-0142(197210)30:4<914::aid-cncr2820300409>3.0.co;2-8.
8
Current status of PEP bleomycin studies in Japan.日本博来霉素暴露后预防（PEP）研究的现状。
Recent Results Cancer Res. 1981;76:41-60. doi: 10.1007/978-3-642-81565-2_5.
9
[Results with the cytostatic agent bleomycin in tumour therapy (author's transl)].[细胞抑制剂博来霉素在肿瘤治疗中的结果（作者译）]
Wien Klin Wochenschr. 1973 Oct 19;85(42):686-92.
10
Effect of bleomycin on squamous cell carcinoma: preliminary observations.博来霉素对鳞状细胞癌的影响：初步观察
N S Med Bull. 1972 Oct;51(5):144-50.
Zotero 插件